Skip to content

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB · XNAS

CIK 1299130fmd_1F347RK5EZSR72EX3DZWBWXZQPManufacturing · Laboratory Analytical InstrumentsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues9193799179131128201154160
Cost of revenue47595456467279148117114
Gross profit44352535335949533746
Research and development686563606411319318713597
Selling, general and administrative4859637573124161170175141
Total operating expenses115124126135137269356387512600
Operating income(71)(90)(101)(101)(104)(210)(307)(334)(474)(554)
Interest expense33230131514137
Other non-operating income (expense)0111208332415
Income before taxes(74)(92)(102)(84)29(275)(314)(318)(310)(546)
Income tax expense–––––(94)0(11)00
Net income from continuing operations–––––(181)(314)(307)(310)(546)
Net income(74)(92)(103)(84)29(181)(314)(307)(310)(546)
Net income to common shareholders––––––(314)(307)(310)(546)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) financial statements · FinancialMD